Novel anticoagulants for stroke prevention in atrial fibrillation: a systematic review of cost-effectiveness models.
<h4>Objective</h4>To conduct a systematic review of economic models of newer anticoagulants for stroke prevention in atrial fibrillation (SPAF).<h4>Patients and methods</h4>We searched Medline, Embase, NHSEED and HTA databases and the Tuft's Registry from January 1, 2008...
Guardado en:
Autores principales: | Brendan L Limone, William L Baker, Jeffrey Kluger, Craig I Coleman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/59668994e1e147bdafc6e20c4c0bcf5a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Anticoagulation Control in Different Ethnic Groups Receiving Vitamin K Antagonist for Stroke Prevention in Atrial Fibrillation
por: Nur Azyyati Zawawi, et al.
Publicado: (2021) -
Does novel oral anticoagulant improve anticoagulation for non-valvular atrial fibrillation associated stroke: An inpatient registration study in Shanghai
por: Feng-Di Liu, et al.
Publicado: (2015) -
Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants
por: Turagam MK, et al.
Publicado: (2015) -
Oral anticoagulation to reduce risk of stroke in patients with atrial fibrillation: current and future therapies
por: Amin A
Publicado: (2013) -
ANTICOAGULATION CONTROL AMONG PATIENTS WITH ATRIAL FIBRILLATION
por: Amer Rauf, et al.
Publicado: (2020)